Hexagon Capital Partners LLC Novo Cure LTD Transaction History
Hexagon Capital Partners LLC
- $546 Million
- Q4 2024
A detailed history of Hexagon Capital Partners LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 12 shares of NVCR stock, worth $261. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 4
200.0%
Holding current value
$261
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NVCR
# of Institutions
289Shares Held
75.6MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$265 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$257 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$194 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$105 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$59.8 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.29B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...